Skip to main

InVivo Therapeutics

NVIV is nowNVIVQ
NVIV logo
This stock has changed its ticker name. This happens for a variety of reason, including a corporate merger or simply a change in company name.
Learn More
Go to the new stock page

Frequently Asked Questions (FAQ)

As of Dec 04, 2025, the market cap for NVIV stock is $1.15M

The current P/E ratio for NVIV stock is -0.11

The 52-week high for NVIV stock is $0.43. The current NVIV stock price $undefined is 100.00% below its 52-week high

The 52-week low for NVIV stock is $0.15. The current NVIV stock price $undefined has increased 100.00% from its 52-week low

No, the NVIV stock does not pay dividends to its shareholders

How to buy NVIV stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in NVIV stock

    Navigate to the Explore page. Then, type NVIV into the search bar. When you see NVIV stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased NVIV stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

InVivo Therapeutics Stock Earnings

The value each NVIV share was expected to gain vs. the value that each NVIV share actually gained.

InVivo Therapeutics (NVIV) reported earnings per share (EPS) of $0, estimates of $0 by . In the same quarter last year, InVivo Therapeutics's earnings per share (EPS) was $0. InVivo Therapeutics is expected to release next earnings on 11/08/2023, with an earnings per share (EPS) estimate of $0.

Buy InVivo Therapeutics (NVIV) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.